Endothelial Function in Young Hispanic Adults at Risk for Type 2 Diabetes
Study Details
Study Description
Brief Summary
Diabetes is a major public health problem. Hispanics/Latinos are known to be at higher risk for type 2 diabetes. The function of the endothelium has played a key role in the understanding of vascular complications in people with diabetes. Endothelial function and vascular reactivity are impaired not only in white adults with type 2 diabetes but also in those at risk for the disease by virtue of having impaired glucose tolerance or parental history of type 2 diabetes. Whether this finding is applicable to hispanics is not known. The investigators plan to assess the endothelial function and vascular reactivity in young Hispanic adults at risk of developing type 2 diabetes by virtue of being obese and belonging to a minority population.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
adults at risk Latino adults with family history of type 2 diabetes |
|
controls Latino adults without family history of type 2 diabetes and normal glucose tolerance |
Outcome Measures
Primary Outcome Measures
- markers of endothelial activation, coagulation and inflammation [cross sectional evaluation]
Eligibility Criteria
Criteria
Inclusion Criteria:
- Group 1:
-
Age between 18-40 years;
-
Hispanic (we will consider a subject being Hispanic if both parents are reported as Hispanics when asked the following question: "What ethnic group do you consider that you belong to?");
-
History of type 2 diabetes in one or both parents;
-
BMI above 27;
-
Not have participated in any exercise program for the 6 months prior to the beginning of the study.
Group 2:
-
Age between 18-40 years;
-
Hispanic (same criteria as above );
-
No history of type 2 diabetes in any first degree relative;
-
BMI under 25;
-
Not have participated in any exercise program for the 6 months prior to the beginning of the study.
Exclusion Criteria:
- diabetes, glucose intolerance, pregnancy, smoking, cardiovascular disease, uncontrolled hypertension, renal disease, proteinuria, cancer, infectious diseases, severe GI diseases, lung disease, electrolyte abnormalities, anemia, endocrine disorders, severe dyslipidemia, peripheral vascular disease, medications: beta-blockers, any diuretic, calcium channel blockers, ACE inhibitors, angiotensin receptor blockers, niacin, glucocorticoids, any antineoplastic agent, antibiotics, psychoactive agents, bronchodilators or insulin.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Joslin Diabetes Center | Boston | Massachusetts | United States | 02215 |
Sponsors and Collaborators
- Joslin Diabetes Center
Investigators
- Principal Investigator: Enrique Caballero, MD, Joslin Diabetes Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CHS#: 03-30